RUNX1 has been demonstrated to be downregulated in glioma, acute myeloblastic leukemia (AML) and gastric cancer; however, overexpression of RUNX1 in glioma, AML and gastric cancer reduced malignant progression [24]. The gene discussed is RUNX1; the disease is gastric cancer.